» Articles » PMID: 36834987

Expression of Epithelial and Mesenchymal Markers in Plasmatic Extracellular Vesicles As a Diagnostic Tool for Neoplastic Processes

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Feb 25
PMID 36834987
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor-derived extracellular vesicles (TD-EVs) have active roles as cancer hallmark enablers. EVs RNA of epithelial and stromal cells carry information that facilitates the communication processes that contribute to oncological progression, so the objective of this work was to validate by RT-PCR the presence of epithelial (; ) and stromal (; ) markers in RNA of plasmatic EVs in healthy and diverse-malignancy patients for the development of a non-invasive cancer diagnosis system using liquid biopsy. Ten asymptomatic controls and 20 cancer patients were included in the study, and results showed that the isolated plasmatic EVs by scanning transmission electron microscopy (STEM) andBiomedical Research Institute A Coruña nanoparticle tracking analysis (NTA) contained most exosome structures with also a considerable percentage of microvesicles. No differences were found in concentration and size distribution between the two cohorts of patients, but significant gene expression in epithelial and mesenchymal markers between healthy donors and patients with active oncological disease was shown. Results of quantitative RT-PCR are solid and reliable for , , and , so the analysis of RNA extracted from TD-EVs could be a correct approach to develop a diagnostic tool in oncological processes.

Citing Articles

Simultaneous Detection of Collagen I Alpha II and Cytokeratin 19 mRNA by Multiplex qPCR in Liquid Biopsy in Diagnosis of Patients with Resectable Solid Tumors.

Estevez Perez L, Alen B, Otero Alen M, Hormaetxe S, Simon L, Concha A Int J Mol Sci. 2024; 25(17).

PMID: 39273514 PMC: 11395584. DOI: 10.3390/ijms25179567.


Unraveling the metastatic niche in breast cancer bone metastasis through single-cell RNA sequencing.

Li X, Gao Z, Yang M, Yang C, Yang D, Cui W Clin Transl Oncol. 2024; 27(2):671-686.

PMID: 39066875 DOI: 10.1007/s12094-024-03594-2.


Cancer screening with multicancer detection tests: A translational science review.

Rubinstein W, Patriotis C, Dickherber A, Han P, Katki H, LeeVan E CA Cancer J Clin. 2024; 74(4):368-382.

PMID: 38517462 PMC: 11226362. DOI: 10.3322/caac.21833.

References
1.
Grunnet M, Sorensen J . Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer. 2011; 76(2):138-43. DOI: 10.1016/j.lungcan.2011.11.012. View

2.
Xu D, Li X, Zheng S, Jiang W . Quantitative real-time RT-PCR detection for CEA, CK20 and CK19 mRNA in peripheral blood of colorectal cancer patients. J Zhejiang Univ Sci B. 2006; 7(6):445-51. PMC: 1474001. DOI: 10.1631/jzus.2006.B0445. View

3.
Bager C, Willumsen N, Leeming D, Smith V, Karsdal M, Dornan D . Collagen degradation products measured in serum can separate ovarian and breast cancer patients from healthy controls: A preliminary study. Cancer Biomark. 2015; 15(6):783-8. DOI: 10.3233/CBM-150520. View

4.
LeBleu V, Kalluri R . Exosomes as a Multicomponent Biomarker Platform in Cancer. Trends Cancer. 2020; 6(9):767-774. DOI: 10.1016/j.trecan.2020.03.007. View

5.
Pavlou M, Diamandis E, Blasutig I . The long journey of cancer biomarkers from the bench to the clinic. Clin Chem. 2012; 59(1):147-57. DOI: 10.1373/clinchem.2012.184614. View